Bender Bruce G
National Jewish Medical and Research Center, Denver, Colorado 80206, USA.
J Allergy Clin Immunol. 2002 Jun;109(6 Suppl):S554-9. doi: 10.1067/mai.2002.124570.
Inadequate patient adherence to prescribed treatment regimens is a major cause of poor clinical outcomes in the treatment of asthma. Among children with asthma, adherence rates are often below 50%. Multiple treatment-, clinician-, and patient-related barriers prevent the achievement of satisfactory levels of adherence. Treatment-related barriers include prolonged and complex regimens, adverse effects, cost, and delayed onset of action. Clinician-related barriers include difficulty in scheduling, treatment by one different care giver after another, perceived clinician disinterest, and time constraints. Patient-related barriers include mild or severe asthma, poor understanding of the need for treatment, insufficient confidence in the clinician or medication, the presence of psychological problems, and low motivation to change behavior. Although all of these factors must be addressed to maximize adherence, patient motivation may be the most critical. This task falls primarily to clinicians (physicians, nurses, staff), and it requires thorough patient and care giver education, more frequent patient contact, and the development of a patient-clinician partnership dedicated to the effective treatment of asthma.
患者对规定治疗方案的依从性不足是哮喘治疗中临床疗效不佳的主要原因。在哮喘儿童中,依从率往往低于50%。多种与治疗、临床医生和患者相关的障碍阻碍了达到令人满意的依从水平。与治疗相关的障碍包括疗程长且复杂、不良反应、费用以及起效延迟。与临床医生相关的障碍包括安排就诊困难、由不同的护理人员依次进行治疗、临床医生缺乏关注以及时间限制。与患者相关的障碍包括轻度或重度哮喘、对治疗必要性理解不足、对临床医生或药物缺乏信心、存在心理问题以及改变行为的动力不足。尽管必须解决所有这些因素以最大限度地提高依从性,但患者的动力可能是最关键的。这项任务主要落在临床医生(医生、护士、工作人员)身上,这需要对患者和护理人员进行全面教育、更频繁地与患者接触,并建立致力于有效治疗哮喘的患者 - 临床医生伙伴关系。